观点医药

China to drive a weight-loss drug price war
manbetx3.0 将推动减肥药价格战

The active ingredient semaglutide is starting to lose patent protection and China can produce GLP-1 related treatments at scale
司美格鲁肽在主要市场的专利保护即将到期。manbetx3.0 拥有足够的生产规模,能够以低价生产这些药物。

Obesity rates are on the rise globally with more than 1bn adults now classified as living with obesity. What was once mostly an adult condition is also reshaping childhood. For the first time in history, there are more children living with obesity than those who are underweight, according to Unicef.

manbetx app苹果 肥胖率持续上升,目前已有超过10亿成年人被诊断为肥胖。这种曾经主要影响成年人的疾病,如今也正在改变儿童的生活。据联合国儿童基金会(Unicef)统计,历史上首次出现肥胖儿童数量超过体重不足儿童数量的情况。

您已阅读7%(404字),剩余93%(5671字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×